The European Platform for Neurodegenerative Diseases (EPND) is excited to kick off its 2025 public webinar series with an interactive discussion on collaborative research in neurodegeneration. In this episode, Phil Scordis, Head of Patient Data Analytics at UCB Pharma, will explore how EPND is enabling new pathways for data-driven discoveries in neurodegenerative disease research. Matt Clement, Director for Health & Life Sciences at Gates Ventures, will introduce EPND’s technical Hub, a platform now featuring 100 research studies across 12 neurodegenerative disease areas, representing over 265,000 research participants. ​

Join the webinar to discover how EPND’s technical capabilities and support services can accelerate your research. From accessing a vast and growing collection of datasets and biosamples to leveraging secure, collaborative workspaces for advanced analysis, EPND provides essential tools and infrastructure to facilitate research. EPND's Hub can offer end-to-end support - whether you're seeking to access diverse data sources, streamline your study workflow, or collaborate with experts across Europe and beyond. ​

There'll be plenty of time for Q&A, so come armed with questions!

Click here to register for the Webinar: https://us02web.zoom.us/meeting/register/rntCBg8uR0WWwoPSTKKKew

EPND Webinar: Introducing the EPND Hub, a unified platform for data and biosample sharing

Date: Thursday 22 May, between 3-4pm CET

Moderator: Phil Scordis, EPND co-Lead

Agenda and Speakers:

The European Platform for Neurodegenerative Diseases: enabling new pathways for collaborative research

Phil Scordis, Head of Patient Data Analytics, UCB Pharma

EPND's technical Hub: streamlining discovery, access and sharing of datasets & biosamples from neurodegeneration research

Matt Clement, Director, Health and Life Sciences, Gates Ventures